CompletedNot Applicable

Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study

Canada144 participantsStarted 2014-10

Plain-language summary

Studies show that cancer survivors have unmet needs, the most frequently cited being fear of recurrence (FCR). Moderate to high levels of FCR have been reported by as much as 49% of cancer patients and are more prevalent among women. FCR is associated with psychological distress, lower quality of life, and increased health care utilization. Little evidence exists that these problems are being addressed by current medical management.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. first diagnosis of BC or GC with stages between I-III;
✓. disease-free at the start of the group;
✓. women aged 18 years or older;
✓. completion of treatment, with the exception of adjuvant chemotherapy or hormonal replacement therapy

Exclusion criteria

✕. non-English speakers
✕. previous cancer recurrence
✕. enrolled in another group psychotherapy at the time of the start of the study or during the course of the 6 sessions
✕. unresolved mental health disorder judged to be clinically contra-indicated and/or likely to affect the group work, based on disclosure by the potential participant or clinically identified by the group leader.

What they're measuring

Fear of cancer recurrence inventory

Timeframe: up to 12 months post-intervention follow-up

Trial details

NCT IDNCT03270995

SponsorMcGill University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-01

View on ClinicalTrials.gov More Breast Neoplasms trials